Explore more publications!
Health Wire Kuwait
Got News to Share?

Health Wire Kuwait: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Kuwait.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on April 15, 2026

Sarla Technologies Joins the AVEVA Partner Ecosystem as a System Integrator with Focus on AVEVA PI System
20 minutes ago

Sarla Technologies Joins the AVEVA Partner Ecosystem as a System Integrator with Focus on AVEVA PI System

Indeterminate EIN Presswire
OSE Immunotherapeutics to Present a Novel, First-in-Class, FPR2 Agonist Monoclonal Antibody in the Resolution of Chronic Inflammation at the AAI 2026 Meeting
2 hours ago

OSE Immunotherapeutics to Present a Novel, First-in-Class, FPR2 Agonist Monoclonal Antibody in the Resolution of Chronic Inflammation at the AAI 2026 Meeting

Indeterminate GlobeNewswire
OSE Immunotherapeutics présentera un nouvel anticorps monoclonal, first-in-class, agoniste de FPR2 dans la résolution de l’inflammation chronique au Congrès 2026 de l’AAI
2 hours ago

OSE Immunotherapeutics présentera un nouvel anticorps monoclonal, first-in-class, agoniste de FPR2 dans la résolution de l’inflammation chronique au Congrès 2026 de l’AAI

Indeterminate GlobeNewswire
BioVersys to Present Data on Clinical and Preclinical Pipeline Programs at ESCMID Global 2026
2 hours ago

BioVersys to Present Data on Clinical and Preclinical Pipeline Programs at ESCMID Global 2026

Indeterminate GlobeNewswire
Revolution Medicines, Inc. Prices $2.0 Billion in Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes
3 hours ago

Revolution Medicines, Inc. Prices $2.0 Billion in Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes

Indeterminate GlobeNewswire
Spyre Therapeutics Announces Pricing of Upsized $403.0 Million Public Offering of Common Stock
5 hours ago

Spyre Therapeutics Announces Pricing of Upsized $403.0 Million Public Offering of Common Stock

Indeterminate GlobeNewswire
LECOM Makes Pharmacy Education More Accessible with Three Fully Accredited Doctor of Pharmacy Pathways
5 hours ago

LECOM Makes Pharmacy Education More Accessible with Three Fully Accredited Doctor of Pharmacy Pathways

Indeterminate GlobeNewswire
Allogene Therapeutics Announces Pricing of Public Offering of Common Stock
6 hours ago

Allogene Therapeutics Announces Pricing of Public Offering of Common Stock

Indeterminate GlobeNewswire
American Addiction Centers and Filmmaker Jeffrey Shulman Team Up to Promote Powerful New Film on Addiction and Recovery with National Theatrical Tour
6 hours ago

American Addiction Centers and Filmmaker Jeffrey Shulman Team Up to Promote Powerful New Film on Addiction and Recovery with National Theatrical Tour

Indeterminate GlobeNewswire
Arc TRT Launches New Website to Help UK Men Access Personalised Testosterone Replacement Therapy
6 hours ago

Arc TRT Launches New Website to Help UK Men Access Personalised Testosterone Replacement Therapy

Indeterminate GlobeNewswire
EpimAb Biotherapeutics to Present a Novel Prodrug T-Cell Engager (ProTCE) Platform at the 2026 American Association for Cancer Research Annual Meeting
6 hours ago

EpimAb Biotherapeutics to Present a Novel Prodrug T-Cell Engager (ProTCE) Platform at the 2026 American Association for Cancer Research Annual Meeting

Indeterminate GlobeNewswire
Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products
7 hours ago

Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions